Pharming Group NV (PHAR), a Dutch biopharmaceutical company, said on Tuesday that its Board has nominated Fabrice Chouraqui to become its Chief Executive Officer to succeed Sijmen de Vries.
The company will nominate Chouraqui for the appointment as CEO for a term of four years at an upcoming extraordinary general meeting of shareholders.
Upon the appointment, Vries will resign from the Board. However, he will remain as a strategic advisor to the new CEO until December 31.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.